Experience

Foghorn Therapeutics Inc.

• United States
• Biotechnology Research
• 100 - 200 Employee

• Senior Scientist

  • Jul 2022 - Present

  Targeted Degradation Platform Targeted Degradation Platform



Boston Children's Hospital & Harvard Medical School

• Postdoctoral Research Fellow

  • Aug 2012 - Jul 2022

  Utilized single-cell datasets to generate a number of new in vivo reporters for genetically inaccessible glial cell types in C. elegans Discovered new genes that are required for glial cell development and function through genome-wide, unbiased mutagenesis screens Developed assays for the execution of a high-throughput, whole organismal drug-screening platform for the human neurological disorder Kabuki syndrome modeled in C. elegans Utilized single-cell datasets to generate a number of new in vivo reporters for genetically inaccessible glial cell types in C. elegans Discovered new genes that are required for glial cell development and function through genome-wide, unbiased mutagenesis screens Developed assays for the execution of a high-throughput, whole organismal drug-screening platform for the human neurological disorder Kabuki syndrome modeled in C. elegans



Boston College

• United Kingdom
• Education Administration Programs
• 100 - 200 Employee

• Adjunct Faculty

  • Jan 2021 - May 2021

  Instructor of record for Introduction to Genomics course Instructor of record for Introduction to Genomics course



Harvard Medical School

• United States
• Higher Education
• 700 & Above Employee

• Graduate Student

  • Aug 2006 - Aug 2012

  Discovered a new role for Notch signaling in the establishment of cell identity after exit from progenitor state in the vertebrate retina Performed single-cell profiling experiments of wild-type and Notch1- mutant retinal cells to determine novel targets downstream of Notch signaling Identified functional roles for new Notch1 downstream target genes through in vivo misexpression and RNAi assays Discovered a new role for Notch signaling in the establishment of cell identity after exit from progenitor state in the vertebrate retina Performed single-cell profiling experiments of wild-type and Notch1- mutant retinal cells to determine novel targets downstream of Notch signaling Identified functional roles for new Notch1 downstream target genes through in vivo misexpression and RNAi assays